MPIA
GSK icon

Mountain Pacific Investment Advisers’s GSK GSK Stock Holding History

Mountain Pacific Investment Advisers’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-330
Closed -$17K – 160
2018
Q3 		$17K Buy
+330
New +$16.8K ﹤0.01% 233

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Mountain Pacific Investment Advisers's GSK Position: Q4 2018 in Review

Mountain Pacific Investment Advisers sold out of GSK (GSK) in Q4 2018, closing a stake of 330 shares — an estimated $17K sold.

Mountain Pacific Investment Advisers first reported a position in GSK in Q3 2018 and held it in 1 quarter. The position peaked at $17K in Q3 2018. 799 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

  • Mountain Pacific Investment Advisers reported no remaining GSK position as of Q4 2018 after selling out during the quarter.
  • Mountain Pacific Investment Advisers sold 330 GSK shares in Q4 2018, an estimated $17K.
  • Mountain Pacific Investment Advisers first reported a position in GSK in Q3 2018 and held it in 1 quarter.
  • Mountain Pacific Investment Advisers's GSK position peaked at $17K in Q3 2018.
  • 799 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on Mountain Pacific Investment Advisers's 13F filing for Q4 2018, filed 25 Jan 2019.